Phase 1 Oral Solution Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the bioavailability of Apixaban solution administered
through NGT and washed with Dextrose 5% in water (D5W) or infant formula relative to Apixaban
solution administered orally in healthy subjects